期刊名称：CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY ISSN： 2163-8306 出版频率： Monthly 出版社： WILEY, 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774   出版社网址： https://ascpt.onlinelibrary.wiley.com/loi/21638306 期刊网址： https://ascpt.onlinelibrary.wiley.com/loi/21638306 影响因子： 4.054 主题范畴： PHARMACOLOGY & PHARMACY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal CPT: Pharmacometrics & Systems Pharmacology (PSP) is an official open access journal of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Aims and Scope   CPT: Pharmacometrics & Systems Pharmacology is a cross-disciplinary journal devoted to publishing advances in quantitative (e.g., modeling and simulation) methods as applied in pharmacology, physiology and therapeutics in humans. The journal welcomes original research articles, reviews and tutorials that bridge the following areas: pharmacometrics, modeling and simulation as applied to the design and evaluation of clinical trials, systems pharmacology modeling, particularly with a mechanistic link to human (patho)physiology, disease modeling, “population” or mixed-effects pharmacokinetics and pharmacodynamics (PKPD) modeling, modeling and simulation to support translational research, physiologically-based pharmacokinetics (PBPK), model-based meta-analyses of clinical trials, mechanism-based pharmacokinetic-pharmacodynamic modeling, computational pharmacology, bioinformatics, comparative efficacy, effectiveness and cost-effectiveness. Systems pharmacology may involve the application of systems biology approaches to study drug activities, targets and effects. The discipline is often defined with reference to engineering and pharmacological principles as the quantitative analysis of the dynamic interactions between drugs and a biologic system that aims to understand the behavior of the system as a whole. The common focus will be on quantitative methods that improve our understanding of pharmacology and therapeutics in humans. Abstracting and Indexing Information   CAS: Chemical Abstracts Service (ACS) Embase (Elsevier) MEDLINE/PubMed (NLM) PubMed via PMC deposit (NLM) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier)   Instructions to Authors Manuscript Preparation Guidelines Content Types | Peer Review Process | Manuscript Format | Open Access Publication Editorial Policies Post-Acceptance Information Editorial Board Editor-in-Chief France Mentré, MD, PhD School of Medicine of University Paris Diderot (Paris 7) Paris, France Deputy Editor-in-Chief Lena Friberg, PhD Uppsala University Sweden Associate Editors   Jonathan French, ScD Metrum Research Group Tariffville, CT, USA Stefanie Hennig, PhD Certara, L.P. Brisbane, Australia Sriram Krishnaswami, PhD Pfizer Groton, CT, USA Karen Rowland Yeo, PhD Certara UK, Ltd.  Sheffield, UK Vikram Sinha, PhD Takeda Pharmaceuticals International Co. Cambridge, MA, USA Eric Sobie, PhD Icahn School of Medicine at Mount Sinai New York, NY, USA Ping Zhao, PhD Bill & Melinda Gates Foundation Seattle, WA, USA Editors-in-Training Vivaswath S. Ayyar, PhD Janssen Research & Development Spring House, PA Natasha Strydom, PhD  University of California San Francisco  San Francisco, CA   Editorial Board   Ioannis Androulakis, PhD Rutgers University Surgery, UMDNJ-RWJ Medical School Piscataway Township, NJ, USA Joseph P Balthasar, PhD University of Buffalo Buffalo, NY, USA Robert Bies, PharmD, PhD State University of New York at Buffalo Buffalo, NY, USA Marc Birtwistle, PhD Clemson University Clemson, SC, USA Marylore Chenel, PharmD, PhD Pharmetheus Uppsala, Sweden Paolo Denti, PhD University of Cape Town Cape Town, South Africa James M. Gallo, PharmD, PhD University at Buffalo Buffalo, NY, USA Christine Garnett, PhD US Food and Drug Administration Silver Spring, MD, USA Ekaterina Gibiansky, PhD QuantPharm LLC North Potomac, MD, USA Manish Gupta, PhD GenMab Princeton, NY, USA Bart Hendriks, PhD Merrimack Pharmaceuticals Cambridge, MA, USA Nick Holford, MBChB The University of Auckland Auckland, New Zealand Brett A. Howell, PhD DILIsym Services Inc., a Simulations Plus company Research Triangle Park, NC, USA Kristin Karlsson, PhD Swedish Medical Products Agency Uppsala, Sweden Ron Keizer, PhD InsightRX San Francisco, CA, USA Steven E. Kern, PhD Bill & Melinda Gates Foundation Seattle, WA, USA Andrzej Kierzek, PhD Certara QSP  Sheffield, United Kingdom Wei Lu, PhD Peking University/Pfizer Pharmacometrics Beijing, China Rajanikanth (Raj) Madabushi, PhD US Food and Drug Administration Silver Spring, MD, USA Efthymios Manolis, MSc European Medicines Agency London, UK Peter Milligan, PhD Pharmetheus Uppsala, Sweden Kyungsoo Park, MD, PhD Yonsei University College of Medicine Seoul, Republic of Korea Marc Pfister, MD University of Basel Basel, Switzerland Jose Pinheiro, PhD Johnson and Johnson Pharmaceutical Research Raritan, NJ, USA Benjamin Ribba, PhD F. Hoffman-La Roche Basel, Switzerland Daniel Scholes Rosenbloom, PhD Merck & Co. Rahway, NJ, USA Julio Saez-Rodriguez, PhD RWTH Aachen University  Aachen, Germany Radojka Savic, PhD University of California Oakland CA, USA Virginia D. Schmith, PhD Nuventra Pharma Sciences Durham, NC, USA Joe Standing, PhD University College London London, UK Yuichi Sugiyama, PhD Riken Innovation Center Sugiyama Laboratory Yokohama, Japan Joel Tarning, PhD Mahidol-Oxford Tropical Medicine Research Unit Bangkok, Thailand Nicholas Tatonetti, PhD Columbia University New York, NY, USA Paolo Vicini, PhD Department of Clinical Pharmacology and DMPK at Med Immune Cambridge, UK Hua Xu, PhD University of Texas Health Science Center Houston, Texas, USA Ping Zhang, PhD The Ohio State University Columbus, OH, USA American Society for Clinical Pharmacology & Therapeutics Chief Executive Officer Sharon J. Swan Chief Operating Officer Elise S. Laffman-Johnson Managing Editor Alethea B. Gerding   Deputy Managing Editor Alaina Webster   Senior Editorial Coordinator Aimee Greene